CARA - Cara Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts9299
Avg. Estimate-0.66-0.61-2.56-2.38
Low Estimate-0.86-0.64-2.73-3.25
High Estimate-0.41-0.59-2.28-1.67
Year Ago EPS-0.52-0.56-2.06-2.56
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts9299
Avg. Estimate4.79M4.9M20.12M26.56M
Low EstimateN/A4.5M15.2M19.33M
High Estimate6.5M5.3M21.87M48.5M
Year Ago Sales5.53M2.96M13.47M20.12M
Sales Growth (year/est)-13.40%65.50%49.40%32.00%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.58-0.58-0.61-0.58
EPS Actual-0.52-0.56-0.58-0.74
Difference0.060.020.03-0.16
Surprise %10.30%3.40%4.90%-27.60%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.66-0.61-2.56-2.38
7 Days Ago-0.66-0.61-2.56-2.38
30 Days Ago-0.66-0.61-2.56-2.35
60 Days Ago-0.57-0.74-2.28-2.25
90 Days Ago-0.57-0.74-2.28-2.25
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCARAIndustrySectorS&P 500
Current Qtr.-26.90%N/AN/A0.01
Next Qtr.-8.90%N/AN/A0.06
Current Year-24.30%N/AN/A-0.03
Next Year7.00%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A